Stratec Agrees Sale of Diatron MI to Indian Investors

MT Newswires · 1d ago
12:21 AM EST, 11/02/2026 (MT Newswires) -- Stratec (SBS.F) agreed to sell its subsidiary Diatron MI to a consortium of Indian investors for 10 million euros, plus potential earn-out payments. The German biomedical technology company said Oct. 30 the transaction covers Diatron's hematology and clinical chemistry products, while the original equipment manufacturing business in molecular and immunodiagnostics will remain with Stratec. The transaction is expected to close in the fourth quarter.